AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets closed

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
164.71-0.20 (-0.12%)
At close: 4:00PM EDT

164.71 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close164.91
Open164.16
Bid164.00 x 300
Ask165.00 x 200
Day's Range163.75 - 166.25
52 Week Range133.64 - 184.21
Volume4,555,376
Avg. Volume4,012,480
Market Cap121.3B
Beta1.76
PE Ratio (TTM)16.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.78%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    Amgen Awards Three Golden Tickets for LabCentral Residency

    CAMBRIDGE, Mass., March 28, 2017 /PRNewswire/ -- Amgen (AMGN) and LabCentral announced that Cocoon Biotech, Torus Therapeutics, and Holobiome are the winners of Golden Ticket awards. Sponsored by Amgen, the Golden Ticket awards underwrite the cost of a lab bench for a scientist from each organization to reside in LabCentral's open lab for one year. LabCentral is an innovative, shared laboratory space designed as a launchpad for premier high impact life-sciences and biotech startups.

  • Cousins (CUZ) Inks Lease with Amgen at Corporate Center
    Zacks8 hours ago

    Cousins (CUZ) Inks Lease with Amgen at Corporate Center

    Cousins Properties Inc. (CUZ) announced that Amgen has inked a lease at Corporate Center, spanning 125,000 square feet.

  • GuruFocus.com23 hours ago

    Amgen's Humira Biosimilar Approved in Europe

    The treatment has already been approved in the US